Drug intelligence / Profile preview

folic acid + 5-methyltetrahydrofolate

Development stage
Unknown
Lead developer
Merck
Modality
Small Molecules
Administration
Oral
01

Overview

A combination of **folic acid** (synthetic, oxidized form of folate) and **5-methyltetrahydrofolate (5-MTHF)** (the primary natural, bioactive form of folate in circulation). Both are B9 vitamers involved in one-carbon metabolism crucial for DNA synthesis, methylation, and amino acid metabolism. Folic acid requires metabolic reduction by dihydrofolate reductase to become biologically active, whereas 5-MTHF is directly bioavailable and bypasses genetic and functional limitations of folic acid metabolism[1][5]. This combination is used in dietary supplements, especially prenatal vitamins, to ensure adequate folate levels in populations with potentially variable folic acid metabolism due to MTHFR polymorphisms, or in settings where maximizing serum folate (especially 5-MTHF) is desired to prevent neural tube defects, correct deficiency, and support overall methylation pathways[3][5].

Other names
folate mixfolic acid and 5-MTHFfolic acid and 5-methyltetrahydrofolate
02

Targets

MTR (Methionine synthase)DHFR (Dihydrofolate reductase)

Beyond the preview

Go deeper on folic acid + 5-methyltetrahydrofolate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on folic acid + 5-methyltetrahydrofolate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call